Enliven Therapeutics
ELVN
#5643
Rank
S$1.54 B
Marketcap
S$26.12
Share price
3.49%
Change (1 day)
-18.15%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of September 2025 : S$0.5 Million

According to Enliven Therapeutics's latest financial reports the company's total debt is S$0.5 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2025)

Total debt by year

Year Total debt Change
2024-12-31N/A-100%
2023-12-31S$0.44 M2.18%
2022-12-31S$0.43 M101.45%
2021-12-31S$0.21 M54.74%
2020-12-31S$0.13 M